HTRF Anti-VHH-Tb cryptate can be used to capture alpaca and llama VHH nanobodies.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein Quantification |
HTRF Anti-VHH-Tb cryptate can be used to capture alpaca and llama VHH nanobodies.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Monoclonal anti-VHH antibody has been labeled with Tb crypate. Anti-VHH antibody binds to the native form of both alpaca and llama VHH and recombiant nanobodies. The binding is rapid and stable, making it an ideal choice for use in a variety of assays such as nanobodies selection and titration.
Application |
Protein Quantification
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Lysis Buffer Compatibility |
Lysis Buffer 1
Lysis Buffer 2
Lysis Buffer 3
Lysis Buffer 4
|
Product Group |
Fluorescent Reagent
|
Shipping Conditions |
Shipped Ambient
|
Target Class |
Biomarkers
|
Technology |
TR-FRET
|
Unit Size |
5,000 Assay Points
|
In an HTRF interaction assay, one partner is labeled (directly or indirectly) with the donor, and the other with the acceptor (again, directly or indirectly). The intensity of the signal is proportional to the binding of the 2 partners. In the example shown here, anti-VHH-Tb binds to the nanobodies raised against protein A, while partner A* binds to a specific Ab labeled with an HTRF acceptor *partner A can also be biotinylated, tagged, or Fc fused. In these cases, use the corresponding HTRF reagent (anti-Tag, anti-species, protA, Streptavidin) labeled with an acceptor for the detection.
The example on the right describes the protocol using a 20 µL final assay volume for the detection of an interaction between a nanobody raised against protein A and a non-tagged partner A*. Dispense the two partners (10 µL): i.e. protein A+nanobody, add anti-VHH-Tb cryptate (total 5 µL), and anti-partner A labeled with acceptor (5 µL) Then incubate, and finally read. *partner A can also be biotinylated, tagged or Fc fused. In these cases, use the corresponding HTRF reagent (anti-Tag, anti-species, protA, Streptavidin), labeled with an acceptor for the detection.
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
We are here to answer your questions.